Hughes Jones et al. 1957) . In the absence of the -spleen, the removal of the sensitized red cells is very much delayed, having a Ti of the order of :four hours or more (Jandl et al. 1957 , Mollison 1961b . The presence of 6lCr accumulated in the spleen can be detected by surface counting. The use of this test can be illustrated in two patients.
Case 1 It was difficult to determine from a clinical examination the nature of a mobile mass in the left side of the ;abdomen. After injection of 02 ml of the patient's own red cells maximally sensitized with anti-D antibody, the cells were removed from the blood with a Ti of 25 minutes and surface counting revealed that the 5lCr had accumulated in the abdominal mass ( Fig  3) which was therefore a spleen. 10 CFig 3 Surface counting (contour lines of counting rates in counts per second) over an unidentified abdominal mass (thick line) after the destruction of "lCr-labelled ired cells 'coated' with anti-D. The mass must therefore have been a spleen (for full explanation, see text)
,Case 2 A girl, suffering from hereditary spherocytosis, had bad an excellent response to splenectomy at the age of -6, but relapsed twelve years later. No accessory spleen ,could be felt clinically. A sample of her own red cells vas labelled with "'Cr, sensitized with anti-D, and then reinjected intravenously. The cells were removed -with a Ti of 30 minutes and surface counting revealed -accumulation of ""Cr in the left hypochondrium. At operation (Mr H H G Eastcott) an accessory spleen -weighing 200 g was found lying posterior to the -stomach and partially in the lesser sac. This case will. be reported by Eastcott Castle's hematological studies demonstrated that the absorption of vitamin B12 is an extremely complex process which can be interfered with by gastric or intestinal lesions (Berk et al. 1948) . The introduction of radioactive vitamin B12 simplified the study of this unusual absorption and made it possible to follow the subsequent fate of the ingested vitamin. In the last few years, therefore, this material has been widely used, both to study the metabolism of vitamin B12 and to investigate the pathogenesis of vitamin-B12 deficiency (Mollin 1959 , Doig & Girdwood 1960 , Grasbeck 1960 , Witts 1961 . In this paper I propose to discuss the methods used for measuring vitamin-BL2 absorption, describe some of the results in megaloblastic anmmia, and discuss the mechanism of absorption of vitamin B12.
Radioactive Vitamin B12 Vitamin B12 may be labelled with 56Co, 57Co, 58Co or 60Co (Mollin 1959 , Rosenblum 1960 . The biological half-life of vitamin B12 is approximately one year (Schlosser et al. 1958 , Reizenstein 1959 , Glass & Mersheimer 1960 , so it is important that the radiation dose delivered by the labelling isotope should be as small as possible. The radiation dose of 60Co (half-life five years) and 56Co (half-life 77 days) is high, whereas that of 58Co (half-life 71 days) and 67Co (half-life 270 days) is low. For this reason one or other of the latter isotopes is generally used to label vitamin B12 for clinical work. 58Co has a high counting efficiency for all types of counters and is therefore the most suitable label for general use. 57Co iS unsuitable for use with Geiger-Muller counters, or with hepatic or whole-body scintillation counters but, because of its unique scintillation spectrum, is very useful with well-type scintillators (Rosenblum 1960) . It is the label of choice when levels of plasma radioactivity are being measured (Doscherholmen 1961, unpublished) .
Methods ofStudying the Absorption of
Radioactive Vitamin B12 Oral test doses of between 0 5 and 2 0 0tg of vitamin B12 are usually given in these tests. We have found it convenient to use doses of 1-0 Vg of vitamin B12 with a specific activity of 0 5 to 1-0 microcuries.
(1) Faecal excretion method (Heinle et al. 1952 ):
This has been discussed in detail elsewhere (Mollin 1959) . The test dose of radioactive vitamin B12 is given by mouth and the amount excreted in the fmces is measured. The difference between the amount excreted and the amount given is considered to be the amount absorbed. Patients with pernicious anmemia absorb less than 30% of the test dose; normal subjects usually absorb more than 45 % of the dose. In some control subjects absorption may be within the range found in pernicious anemia. In these, however, the parasympathetic stimulant carbachol (carbamylchlorine chloride) increases absorption to within the normal range if it is injected at the same time as the vitamin B12 is taken by mouth . The advantage of this method is that the amount of vitamin B12 absorbed can be measured directly. The disadvantage is that stools may have to be collected for periods of up to six or seven days. Furthermore, if the collection is incomplete, it appears as if the patient had absorbed vitamin B12, an error which may be dangerous. It is doubtful if the method should be used for diagnostic purposes unless the results are checked by the hepatic uptake method or by concurrent measurement of plasma radioactivity (vide infra).
(2) Urinary excretion method of Schilling (1953) : In this method 1 or 2 Fg radioactive vitamin B12 is given by mouth and an injection of 1,000 Vg of non-radioactive vitamin B12 is given at the same time or soon after. The injection of non-radioactive vitamin B12 flushes out about one-third of the absorbed radioactive vitamin B12 into the urine (Callender & Evans 1955) . Patients with pernicious anemia given 1 ,g of 58Co vitamin B12 orally, excrete 5 % or less in their urine in the following twenty-four hours.
This method only requires collection of urine for twenty-four hours and an error due to incomplete collection will not mask malabsorption of vitamin B12. Its main disadvantages are that the patient has to be treated with large doses of vitamin B12 and the results may be inaccurate in serious renal disease (Rath et al. 1957) . It is the method of choice in the already-treated patient.
(3) Hepatic uptake method (Glass, Boyd, Gellin & Stephanson 1954) : A dose of radioactive vitamin B12 is given by mouth, and, after all the unabsorbed radioactivity has been excreted from the alimentary canal, the radioactivity that accumulates in the liver is measured by surface scintillation counting. The amount of vitamin B12 that has been absorbed can be calculated by comparing the hepatic radioactivity, after the oral dose, with the increase in activity produced by a subsequent injection of a known amount of radioactive vitamin BI2.
The great advantage of this method is that it is not dependent on the collection of excreta. Its disadvantage is its need for an injection of radioactive vitamin B12. The test can, however, be used without the injection to determine whether or not absorption has occurred. Used in this way it provides a valuable check on the results of the fical excretion test.
(4) Whole-body counters employing sensitive scintillation spectrometry have recently been used to measure the absorption of radioactive vitamin B12 (Reizenstein et al. 1961) . Patients are given a test dose of 5"Co vitamin B12 by mouth and several days later, when all the unabsorbed material has been excreted, the total amount retained in the tissues is measured in the wholebody counter. Many of the counters in use are very elaborate and expensive, but accurate results can be obtained with much simpler and cheaper arrangements (E H Belcher & B B Anderson, 1961, unpublishedobservation) . Details& of such counters were given at the Symposium on Whole Body Counting held by the International Atomic Energy Agency in Vienna, June 1961.
(5) Plasma radioactivity (Booth & Mollin 1956; Doscherholmen & Hagen 1956; Doscherholmen 1961, unpublished) : In this method the radioactivity of plasma is measured at intervals after the oral dose. In normal subjects there is an increase in plasma radioactivity three hours after the dose which rises to a peak at eight to twelve hours. There is little or no alteration in the plasma radioactivity of patients with pernicious anmmia unless the dose is given with intrinsic factor.
The amount of absorbed vitamin B12 present in the plasma of even normal subjects after physiological doses of vitamin B12 is small, peak levels. being only about 10 ,u,g/ml (Booth & Mollin 1956 ). The amount of radioactivity in the serum is therefore small, and initially we used "6Co vitamin B12 of high specific activity for this test. However, the changes in plasma radioactivity after standard test dose (1.0 ug 58Co or 57CO vitamin B12, specific activity 0 5 to 1 0 ,uc) can easily be measured with modern equipment (Doscherholmen 1961, unpublished) .
The method is simple, does not depend on the collection of excreta and allows a result to be obtained within eight to twelve hours of giving the oral dose. The test is particularly helpful in bedridden or incontinent patients, or when tests have to be carried out on patients at a distance.
The Absorption of Radioactive Vitamin B12 in B12-Deficiency States
Studies with radioactive vitamin B12 in patients with B%2-deficiency due to gastric lesions or to intestinal malabsorption syndrome have confirmed Castle's view that the absorption of vitamin B12 depends, first, on the adequate secretion of intrinsic factor and, secondly, on normal intestinal function. Results obtained by Dr C C Booth and myself on such patients are summarized in"Tables 1 and 2. The group of patients with total gastrectomy showed the lowest absorption, almost certainly because these patients do not secrete any intrinsic factor. Absorption was least affected in the patients with megaloblastic anemia associated with partial gastrectomy. In this group the htmatological signs of vitamin-BL2 deficiency were minimal, presumably because they secreted small amounts of intrinsic factor. The results in pernicious anemia fell between these two groups: many absorbed as little vitamin B12 as the patients who had undergone total gastrectomy; others, however, absorbed significant amounts of vitamin B12 . All these patients absorb normal amounts of radioactive vitamin B12 when the dose is given with adequate amounts of human gastric juice or of potent hog intrinsic factor concentrate.
Absorption was within the range found in pernicious antmia (1) in all the patients with vitamin B12-deficiency associated with anatomical lesions of the small intestine (strictures, blind loops, anastomoses or resections), (2) in 60% of the patients with idiopathic steatorrhaea, and (3) in about 90% of the patients with chronic tropical sprue which we have investigated in this country. In contrast with the previous groups, absorption was not improved when the dose was given with intrinsic factor. Treatment with antibiotics designed to sterilize the gut improves the absorption of vitamin B12 in patients with blind-loop syndrome providing the ileum is intact and not short-circuited (Booth & Mollin 1960 ) and in certain patients with chronic tropical sprue (French et al. 1956 , Baker 1958 , Sheehy & Perez-Santiago 1961 .
Patients with atrophic gastritis may sometimes absorb subnormal amounts ofvitamin B12 , Mollin 1959 ). These patients differ from patients with pernicious anemia in that absorption is sometimes improved by injection of carbachol or by giving the dose with a vitamin-B,2-free meal , Callender et al. 1961 , Deller et al. 1961 ). The precise significance of the effect of carbachol or of the vitamin-Bl2free meal is uncertain. Whatever the explanation, the effect of such stimulation should be tried before concluding that a patient is suffering from achylia gastrica or from subclinical pernicious anaemia.
The Mechanism ofAbsorption of Vitamin B12 Because vitamin B12 is a fairly large molecule, having a molecular weight of 1,500, only a very small proportion of a given dose is absorbed by diffusion. For example, it has been shown that only about 1 % of an oral dose of 3,000 ,ug of crystalline vitamin B12 is absorbed in this way (Ross et al. 1954) . Since a normal diet contains only about 10 ,ug of vitamin B12, it is inconceivable that sufficient vitamin B12 could be absorbed by diffusion to meet the normal daily need of 1 to 3 .tg. Some special mechanism of absorption must therefore be involved.
In man the amount of vitamin B12 that can be absorbed through the agency of intrinsic factor is severely limited , Swendseid et al. 1954 and the ingestion and subsequent absorption of vitamin B1, is followed by a period of from two to three hours during which further absorption is depressed (Abels et al. 1959) . Within the limit of the absorptive capacity of the intestine, however, there appears to be a direct relationship between the amount of vitamin B12 absorbed and the amount of intrinsic factor , Callender & Evans 1955 , Schilling & Schlosser 1957 . The upper limit of the absorptive capacity of the intestine appears to be greater with homologous intrinsic factor (Abels et, al. 1959 , Cooper & Castle 1960 . Furthermore, patients given repeated doses of hog intrinsic factor may become resistant to its actions (Schwartz etal. 1958 ). In such 'resistant' patients doses of hog intrinsic factor, which are usually fully effective, do not promote the absorption of radioactive vitamin B12 and the absorption pattern is similar to that seen in patients with malabsorption syndrome. Human gastric juice (Schwartz et al. 1958) or very large doses of hog intrinsic factor preparations (Berlin et al. 1961 ) may still, however, be effective.
The fact that there is a direct relationship between the amount of vitamin B12 absorbed and the amount of intrinsic factor given, suggests that vitamin B12 and intrinsic factor interact. This is supported by the observation that even the purest preparations of intrinsic factor bind vitamin B12 into a non-diffusible complex (Grdsbeck 1960 , Ellenbogen 1961 . The nature of the bond between vitamin B12 and intrinsic factor is unknown. Vitamin B12 is bound by all proteins, but intrinsic factor can take vitamin B12 from most other proteins, a property which enables the intrinsic factor in gastric juice to compete successfully for vitamin B12 bound to the proteins in food (Cooper & Castle 1960) .
The occurrence of a well-defined upper limit to the amount of vitamin B12 that can be absorbed, led Glass to suggest that there is an intestinal receptor absorption mechanism for the vitamin-B12-intrinsic-factor complex, and that the block to absorption is due to saturation of this receptor . The observation that vitamin B12 is absorbed only in the ileum, supports this view (Booth & Mollin 1959) .
Mode ofAction ofIntrinsic Factor
The absorption of vitamin B12 is a very slow process since little or no vitamin B12 appears in the serum for at least three hours after an oral dose, and it takes twenty-four to forty-eight hours for the whole dose to be absorbed (Booth & Mollin 1959 , Doscherholmen et al. 1960 . Recent studies indicate that the first stage of this complex process (the actual removal of the vitamin-B12-intrinsic-factor complex from the lumen) takes place very rapidly ). This stage is dependent on calcium and can occur after the intestinal cells have been poisoned with metabolic poisons (Herbert 1959a , Cooper & Castle 1960 . The uptake of the vitamin-B12intrinsic-factor complex by the intestinal mucosal cells therefore appears to be the result of a nonenergy-requiring adsorption by a calcium-containing bond (Cooper & Castle 1960) . By this process, the concentration of vitamin B12 at the cell surface is built up. The observation that the absorption of vitamin B12 in man can be interfered with by the administration of EDTA (Grasbeck & Nyberg 1958) or by the administration of sodium phytates (Herbert 1959b ) supports Cooper & Castle's suggestion. What happens afterwards is still uncertain. Cooper & Castle (1960) have demonstrated that extracts of the intestinal wall contain an enzyme that is capable of freeing vitamin B12 from homo-logous but not heterologous intrinsic factor. They suggest that the next stage of absorption is resolution of the calcium-dependent bond by the enzyme and release of free vitamin B12 at the surface or within the mucosal cell. Here again, there is clinical evidence in support of their view. They found that the releasing enzyme was inactive at a pH below 7 0. Many patients with pancreatic steatorrhoea are unable to absorb vitamin B12 even in the presence of intrinsic factor (McIntyre et al. 1956 ). Nieweg et al. (1961 have recently shown that the administration of alkali with the dose of radioactive vitamin B12 restores the absorption of vitamin B12 to normal in such patients.
Obviously, a great deal still remains to be learnt about this aspect of vitamin-B12 metabolism.
Perhaps the question of most interest here is still whether or not an intrinsic-factor-like material has anything to do with the distribution of vitamin B12 within the body (Herbert 1960 ), a problem first raised by the observation that a mixture of vitamin B12 and intrinsic factor ripened megaloblasts in culture more quickly than vitamin B12 alone (Callender & Lajtha 1957) . Further advances, however, in this field, may well depend on the isolation, purification and labelling of intrinsic factor. Iron Metabolism Using Iron 59 (59Fe) as a Tracer by Sheila T Callender MD (Oxford) From the point of view of the clinician, as opposed to the research worker, the three most important questions concerning iron are: (1) Is it being absorbed normally? (2) Is it being utilized normally for red cell formation? (3) Is there any abnormal loss? In the absence of gastro-intestinal bleeding there is negligible excretion of iron from the gut in man. If, therefore, a dose of radioactive iron is given by mouth the amount of that dose which is recovered in the faces represents unabsorbed iron, and from this absorption may be calculated. Although total body counting may ultimately be the most favoured technique for assessing iron absorption, at the present time it is impracticable for the normal laboratory, and the fecal test remains the simplest for this purpose.
In the normal subject with normal body stores, some 70% of the labelled iron which is absorbed from a dose of inorganic iron salt is utilized within the following ten to fourteen days for hmmoglobin synthesis. The remainder goes to body stores. In uncomplicated iron deficiency almost all of that absorbed is incorporated within the next few days in new red cells. In simple iron deficiency, therefore, the measurement of incorporation of labelled iron into red cells may be equated with the total iron absorbed; in the normal subject it is only an approximation and always an underestimate. In more complicated aniemias a greater proportion of the dose may be stored rather than utilized and the figures for red cell utilization may be very different from those for absorption. Thus, although red cell utilization of radioactive iron has been widely used by many workers as a measure of iron absorption it is clearly only applicable to certain groups of subjects. Furthermore, we have some evidence that even in iron deficiency, all the iron absorbed from some forms of food may not be used immediately for red cell production (Bannerman & Callender 1961) .
(1) Absorption Much of the earlier work on absorption of radioactive iron was done using oral doses of the order of 1 mg/kg body weight, which is roughly a therapeutic dose. There are clearly advantages in using such a dose if the problem is solely to discover why a patient does not respond to oral iron. Recently, however, there has been a tendency to use a standard dose of 5 mg of iron as being much nearer to the amount which might be found in one meal. As the dose increases, a smaller percentage is absorbed although it represents a larger amount of total iron. Any test of iron absorption must take into account the dose given and, to make experimental observations comparable, a standard amount of iron should be given.
Two of the most important factors concerned in regulating iron absorption are the rate of erythropoiesis and the amount of stored iron. In general, increased erythropoiesis or reduced iron stores increase absorption of iron, whereas depressed erythropoiesis or increased iron stores reduce it. The combined effect of two opposing factors, e.g. increased erythropoiesis and high iron stores, is unpredictable. The state of the iron stores and the erythropoietic activity must therefore be taken into account when interpreting the results of studies of iron absorption.
The scatter values for iron absorption in socalled normal subjects is very wide. High values may well represent states of latent iron deficiency and are particularly liable to be found in female subjects. In apparently normal control subjects in Oxford absorption from a 5 mg dose of ferrous sulphate varied from 10% to 70 %, with a mean of 27 %; subjects who suffered from an uncomplicated iron deficiency absorbed 32 % to 94 %, with a mean of 61 %. Subjects with malabsorption from idiopathic steatorrhoea are an exception to the rule that diminished iron stores result in increased iron absorption. They absorb much less than normal in spite of their iron deficiency but the malabsorption is corrected by steroids.
We as yet know little about states of relatively poor absorption. Some patients, although not showing the extreme malabsorption of idiopathic steatorrhcea, have a low absorption when considered in the light of their total body needs.
